Well, sadly most journals are to be purchased and institutions already pay their dime for access while the publication is 'free' lol. That is a long disgust discussion and yes, I personally prefer peer reviewed open access platforms. But I guess such debate exceeds the focus of this forum about CYDY. Bottom line, the used journals and authors are credible and widely spread. There is no concentration risk (of manipulation).
Of course, the scientific advisory board is a make-up and many bigger companies do have them. They probably get a few shares and that's it - or they might even believe in the story. Not important to our investment thesis here, personally.
The only thing which made me invest here was the fact that they have reached Combo PE - before that I was watching close, we checked papers and still were like 50/50. Then we waited for the 'touch down' to below 50c and pulled the trigger, finally - after 1.5y of waiting & watching - or is it already 2 years? Therefor, management does everything but pumping. OK, Nader once pumped the golden quarter - guess he had a too good time back then. Biotech, love it or hate it - but you can't time it (o8>
Golden and Proven Science is what we have by now, the rest will be history.
PS: Still keeping eyes open, but you can't beat an achieved peer reviewed PE (o8>
EDIT: Good catch GoldS, re Advisory Board. Sure, they ran around calling 'friends' (o8> However, bottom line is the science. If we would have found anything odd with the authors or data sites etc, that would be significant. Good Night.
EDIT-2: Now it looks funny, surely many on that advisory board are 'animal field' related. Taking it as a practical joke (o8>
News 
Market Data 
Discover 
